A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction (Q81835985)
Jump to navigation
Jump to search
scientific article published on 01 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction |
scientific article published on 01 June 2005 |
Statements
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction (English)
S Tyring
M Lahfa
J Prinz
A M Nakanishi
R Zitnik
P C M van de Kerkhof
Linda Melvin
Etanercept Psoriasis Study Group